×
About 3,510 results

ALLMedicine™ Schizoaffective Disorder Center

Research & Reviews  1,121 results

Deconstructing emotion regulation in schizophrenia: The nature and consequences of abno...
https://doi.org/10.1016/j.schres.2021.12.043
Schizophrenia Research; Bartolomeo LA, Raugh IM et. al.

Jan 14th, 2022 - Prior studies implicate abnormalities at the identification, selection, and implementation stages of Gross' extended process model of emotion regulation in schizophrenia. However, it is unclear whether monitoring dynamics (i.e., emotion regulation...

Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients...
https://doi.org/10.1097/JCP.0000000000001510
Journal of Clinical Psychopharmacology; Wang XY, Chan HY et. al.

Jan 11th, 2022 - This retrospective cohort study aimed at determining whether the daily administration pattern of risperidone influences time to rehospitalization in patients with schizophrenia. Previous studies have related more frequent dosing to poor medication...

Video self-confrontation as a therapeutic tool in schizophrenia: A randomized parallel-...
https://doi.org/10.1016/j.schres.2021.12.016
Schizophrenia Research; Schandrin A, Picot MC et. al.

Jan 7th, 2022 - Lack of insight is a barrier to treating psychosis. Preliminary studies have suggested that showing people videos of their psychotic behaviour may improve personal insight. This clinical trial aimed to assess the effect of video self-confrontation...

A systematic review of TMS and neurophysiological biometrics in patients with schizophr...
https://doi.org/10.1503/jpn.210006
Journal of Psychiatry & Neuroscience : JPN; di Hou M, Santoro V et. al.

Dec 23rd, 2021 - Transcranial magnetic stimulation can be combined with electromyography (TMS-EMG) and electroencephalography (TMS-EEG) to evaluate the excitatory and inhibitory functions of the cerebral cortex in a standardized manner. It has been postulated that...

Race and self-reported paranoia: Increased item endorsement on subscales of the SPQ.
https://doi.org/10.1016/j.schres.2021.11.034
Schizophrenia Research; Wolny J, Moussa-Tooks AB et. al.

Dec 14th, 2021 - There is a dearth of research examining how individual-level and systemic racism may lead to elevated diagnostic and symptom rates of paranoia in Black Americans. The present study employed item response theory methods to investigate item- and sub...

see more →

Drugs  48 results see all →

Clinicaltrials.gov  113 results

Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT03648268

Nov 1st, 2021 - This study proposes to test the hypothesis that the medication refractory experiential (anhedonia and amotivation) and expressive deficits named 'negative symptoms' are mediated by network pathophysiology and the functional connectivity of a cereb...

Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 1
https://clinicaltrials.gov/ct2/show/NCT03896425

Oct 28th, 2021 - Non-invasive neuromodulation, such as transcranial direct current stimulation ( tDCS) , is emerging as an important therapeutic tool with documented effects on brain circuitry, yet little is understood about h ow it changes cognition. In particula...

Multi-component Intervention for Diabetes in Adults With Serious Mental Illness
https://clinicaltrials.gov/ct2/show/NCT03627377

Sep 17th, 2021 - Serious mental illnesses (SMI), including schizophrenia, bipolar disorder, and schizoaffective disorder, are associated with increased medical comorbidity and premature mortality from diabetes and cardiovascular disease. Unhealthy lifestyles, incl...

Ondansetron for Bipolar Disorder and Alcohol Use Disorders
https://clinicaltrials.gov/ct2/show/NCT02082678

Aug 24th, 2021 - A total of 70 outpatients with alcohol use disorder and BPD, cyclothymic disorder, schizoaffective disorder (bipolar type), or MDD with mixed features will be enrolled in a 12-week, randomized, double-blind, parallel-group, placebo-controlled stud...

Spectral Correlation Coefficient-determine TMS for Depression
https://clinicaltrials.gov/ct2/show/NCT04166864

Jul 27th, 2021 - STUDY OBJECTIVE The primary objective of this study is to demonstrate feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) treatment for depression at stimulation frequencies other than 10 Hz. The objectives for this study are: to de...

see more →

News  119 results

Vitamin D Supplements No Help in Early Psychosis
https://www.medpagetoday.com/psychiatry/generalpsychiatry/96413

Dec 28th, 2021 - Steady supplementation with vitamin D did not bolster mental health outcomes for people with first-episode psychosis (FEP), a U.K.-based clinical trial found. Those on a once-monthly regimen of 6 mL of cholecalciferol (equivalent to 120,000 IU of ...

FDA Stands Firm on Deadline for Clozapine REMS Recertification
https://www.medscape.com/viewarticle/962861

Nov 12th, 2021 - Despite objections from the American Psychiatric Association (APA) and other national groups, federal regulators are sticking to the November 15 deadline for the modified clozapine risk evaluation and mitigation strategy (REMS) program. The modifi...

COVID-19: Greater Mortality Among Psych Patients Remains a Mystery
https://www.medscape.com/viewarticle/959884

Sep 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Antipsychotics are not responsible for the increased COVID-related death rate among patients with serious mental illness (SMI), new research shows...

Novel Stroke Rehab Treatment Wins FDA Approval
https://www.medpagetoday.com/neurology/strokes/94253

Aug 27th, 2021 - A novel therapy involving vagus nerve stimulation (VNS) paired with rehabilitation was approved to treat chronic moderate to severe upper extremity motor deficits after ischemic stroke, the FDA announced Friday. "Today's approval of the Vivistim P...

Schizophrenia Meds a Key Contributor to Cognitive Impairment
https://www.medscape.com/viewarticle/952412

Jun 3rd, 2021 - Dr Yash Joshi Anticholinergic medication burden from antipsychotics, antidepressants, and other psychotropics has a cumulative effect of worsening cognitive function in patients with schizophrenia, new research indicates. "The link between long-te...

see more →

Patient Education  3 results see all →